Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandra Solari

Showing results (81-90 of 106) with videos related to

Pageof 11
Sort By:
Neurodegenerative Disease Management|December 16, 2024
Improvements in quality of life of people with relapsing multiple sclerosis treated with cladribine tablets during the 2-year CLARIFY-MS study: a plain language summaryBruno Brochet, Alessandra Solari, Jeannette Lechner-Scott, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|January 12, 2021
The impact of the COVID-19 pandemic on people with neurological disorders: an urgent need to enhance the health care system's preparednessSilvia Zullo, Francesca Ingravallo, Vittorio Crespi, et al.
Trials|April 23, 2015
Home-based palliative approach for people with severe multiple sclerosis and their carers: study protocol for a randomized controlled trialAlessandra Solari, Andrea Giordano, Maria Grazia Grasso, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 18, 2023
Improvements in quality of life over 2 years with cladribine tablets in people with relapsing multiple sclerosis: The CLARIFY-MS studyBruno Brochet, Alessandra Solari, Jeannette Lechner-Scott, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|March 28, 2026
Needs, experiences, and knowledge of people with primary progressive multiple sclerosis: a scoping reviewAndrea Giordano, Giulia Di Domenico, Julia Hickstein, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 16, 2018
eMSQOL-29: Prospective validation of the abbreviated, electronic version of MSQOL-54Rosalba Rosato, Silvia Testa, Antonio Bertolotto, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|October 10, 2023
User appraisal of a booklet for advance care planning in multiple sclerosis: a multicenter, qualitative Italian studyAndrea Giordano, Ludovica De Panfilis, Simone Veronese, et al.
The Lancet. Neurology|March 12, 2011
Ascorbic acid in Charcot-Marie-Tooth disease type 1A (CMT-TRIAAL and CMT-TRAUK): a double-blind randomised trialDavide Pareyson, Mary M Reilly, Angelo Schenone, et al.
Blood|November 18, 2004
Autologous HSCT for severe progressive multiple sclerosis in a multicenter trial: impact on disease activity and quality of lifeRiccardo Saccardi, Gian Luigi Mancardi, Alessandra Solari, et al.
Plos One|October 7, 2014
Unmet needs of people with severe multiple sclerosis and their carers: qualitative findings for a home-based interventionClaudia Borreani, Elisabetta Bianchi, Erika Pietrolongo, et al.
Pageof 11

Showing results (81-90 of 106) with videos related to

Sort By:
Pageof 11
Neurodegenerative Disease Management|December 16, 2024
Improvements in quality of life of people with relapsing multiple sclerosis treated with cladribine tablets during the 2-year CLARIFY-MS study: a plain language summaryBruno Brochet, Alessandra Solari, Jeannette Lechner-Scott, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|January 12, 2021
The impact of the COVID-19 pandemic on people with neurological disorders: an urgent need to enhance the health care system's preparednessSilvia Zullo, Francesca Ingravallo, Vittorio Crespi, et al.
Trials|April 23, 2015
Home-based palliative approach for people with severe multiple sclerosis and their carers: study protocol for a randomized controlled trialAlessandra Solari, Andrea Giordano, Maria Grazia Grasso, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 18, 2023
Improvements in quality of life over 2 years with cladribine tablets in people with relapsing multiple sclerosis: The CLARIFY-MS studyBruno Brochet, Alessandra Solari, Jeannette Lechner-Scott, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|March 28, 2026
Needs, experiences, and knowledge of people with primary progressive multiple sclerosis: a scoping reviewAndrea Giordano, Giulia Di Domenico, Julia Hickstein, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 16, 2018
eMSQOL-29: Prospective validation of the abbreviated, electronic version of MSQOL-54Rosalba Rosato, Silvia Testa, Antonio Bertolotto, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|October 10, 2023
User appraisal of a booklet for advance care planning in multiple sclerosis: a multicenter, qualitative Italian studyAndrea Giordano, Ludovica De Panfilis, Simone Veronese, et al.
The Lancet. Neurology|March 12, 2011
Ascorbic acid in Charcot-Marie-Tooth disease type 1A (CMT-TRIAAL and CMT-TRAUK): a double-blind randomised trialDavide Pareyson, Mary M Reilly, Angelo Schenone, et al.
Blood|November 18, 2004
Autologous HSCT for severe progressive multiple sclerosis in a multicenter trial: impact on disease activity and quality of lifeRiccardo Saccardi, Gian Luigi Mancardi, Alessandra Solari, et al.
Plos One|October 7, 2014
Unmet needs of people with severe multiple sclerosis and their carers: qualitative findings for a home-based interventionClaudia Borreani, Elisabetta Bianchi, Erika Pietrolongo, et al.
Pageof 11